Assembly Biosciences, Inc. Forecast, price target & analysts
Assembly Biosciences, Inc. Target price 2025 - Analyst rating & recommendation
Assembly Biosciences, Inc. Classifications & Recommendation:
Assembly Biosciences, Inc. Price Target
| Target Price | $38.76 |
| Price | $33.13 |
| Potential |
16.99%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Assembly Biosciences, Inc. 2026 .
The average Assembly Biosciences, Inc. target price is $38.76.
This is
16.99%
register free of charge
$52.50
58.47%
register free of charge
$29.29
11.59%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Assembly Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Assembly Biosciences, Inc. stock has an average upside potential 2026 of
16.99%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 28.52 | 32.60 |
| 298.32% | 14.29% | |
| EBITDA Margin | -158.80% | -134.87% |
| 82.29% | 15.07% | |
| Net Margin | -140.88% | -93.31% |
| 83.53% | 33.77% |
7 Analysts have issued a sales forecast Assembly Biosciences, Inc. 2025 . The average Assembly Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Assembly Biosciences, Inc. EBITDA forecast 2025. The average Assembly Biosciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Assembly Biosciences, Inc. Analysts have issued a net profit forecast 2025. The average Assembly Biosciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -6.69 | -3.97 |
| 50.00% | 40.66% | |
| P/E | negative | |
| EV/Sales | 13.01 |
7 Analysts have issued a Assembly Biosciences, Inc. forecast for earnings per share. The average Assembly Biosciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Assembly Biosciences, Inc....
Current Assembly Biosciences, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 14 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Sep 24 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 27 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 24 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 14 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 24 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 27 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 24 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
